274 related articles for article (PubMed ID: 11932410)
1. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro.
Feuer R; Mena I; Pagarigan R; Slifka MK; Whitton JL
J Virol; 2002 May; 76(9):4430-40. PubMed ID: 11932410
[TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency.
Feuer R; Mena I; Pagarigan RR; Hassett DE; Whitton JL
Med Microbiol Immunol; 2004 May; 193(2-3):83-90. PubMed ID: 12925877
[TBL] [Abstract][Full Text] [Related]
3. Coxsackievirus preferentially replicates and induces cytopathic effects in undifferentiated neural progenitor cells.
Tsueng G; Tabor-Godwin JM; Gopal A; Ruller CM; Deline S; An N; Frausto RF; Milner R; Crocker SJ; Whitton JL; Feuer R
J Virol; 2011 Jun; 85(12):5718-32. PubMed ID: 21471247
[TBL] [Abstract][Full Text] [Related]
4. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
5. [The suppressive effect of MiR-490 on coxsackievirus B3 replication].
Wang LL; Zhong ZH; Wang Q; Lu P; Li M; Xu HY
Bing Du Xue Bao; 2014 Nov; 30(6):619-23. PubMed ID: 25868275
[TBL] [Abstract][Full Text] [Related]
6. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.
Bouin A; Vu MN; Al-Hakeem A; Tran GP; Nguyen JHC; Semler BL
J Virol; 2023 Jan; 97(1):e0142622. PubMed ID: 36475766
[TBL] [Abstract][Full Text] [Related]
8. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.
Wang Y; Pfeiffer JK
mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249
[TBL] [Abstract][Full Text] [Related]
9. Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.
Kühnl A; Rien C; Spengler K; Kryeziu N; Sauerbrei A; Heller R; Henke A
Med Microbiol Immunol; 2014 Aug; 203(4):217-29. PubMed ID: 24615265
[TBL] [Abstract][Full Text] [Related]
10. Destabilization of coxsackievirus b3 genome integrated with enhanced green fluorescent protein gene.
Tong L; Lin L; Zhao W; Wang B; Wu S; Liu H; Zhong X; Cui Y; Gu H; Zhang F; Zhong Z
Intervirology; 2011; 54(5):268-75. PubMed ID: 21242657
[TBL] [Abstract][Full Text] [Related]
11. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line.
Pinkert S; Klingel K; Lindig V; Dörner A; Zeichhardt H; Spiller OB; Fechner H
J Virol; 2011 Dec; 85(24):13409-19. PubMed ID: 21976640
[TBL] [Abstract][Full Text] [Related]
12. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes.
Wessely R; Henke A; Zell R; Kandolf R; Knowlton KU
Circulation; 1998 Aug; 98(5):450-7. PubMed ID: 9714096
[TBL] [Abstract][Full Text] [Related]
13. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
14. Human astrocytic cells support persistent coxsackievirus B3 infection.
Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H
J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers.
Robinson SM; Tsueng G; Sin J; Mangale V; Rahawi S; McIntyre LL; Williams W; Kha N; Cruz C; Hancock BM; Nguyen DP; Sayen MR; Hilton BJ; Doran KS; Segall AM; Wolkowicz R; Cornell CT; Whitton JL; Gottlieb RA; Feuer R
PLoS Pathog; 2014 Apr; 10(4):e1004045. PubMed ID: 24722773
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus B3-induced calpain activation facilitates the progeny virus replication via a likely mechanism related with both autophagy enhancement and apoptosis inhibition in the early phase of infection: an in vitro study in H9c2 cells.
Li M; Wang X; Yu Y; Yu Y; Xie Y; Zou Y; Ge J; Peng T; Chen R
Virus Res; 2014 Jan; 179():177-86. PubMed ID: 24177271
[TBL] [Abstract][Full Text] [Related]
18. Direct interferon-gamma-mediated protection caused by a recombinant coxsackievirus B3.
Henke A; Zell R; Martin U; Stelzner A
Virology; 2003 Oct; 315(2):335-44. PubMed ID: 14585336
[TBL] [Abstract][Full Text] [Related]
19. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death.
Kim SM; Park JH; Chung SK; Kim JY; Hwang HY; Chung KC; Jo I; Park SI; Nam JH
J Virol; 2004 Dec; 78(24):13479-88. PubMed ID: 15564459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
